Title : Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.

Pub. Date : 2015 Nov

PMID : 26429918






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONTEXT: The effect of pegvisomant on IGF1 levels in patients with acromegaly is well documented, but little is known of its long-term impact on comorbidity. pegvisomant insulin like growth factor 1 Homo sapiens
2 RESULTS: At the first cardiac evaluation, 20+-16 months after pegvisomant introduction, IGF1 levels normalized in 29 (69%) of the 42 patients. pegvisomant insulin like growth factor 1 Homo sapiens
3 CONCLUSIONS: Long-term pegvisomant therapy not only normalizes IGF1 in a large proportion of patients but also improves cardiac and respiratory comorbidity. pegvisomant insulin like growth factor 1 Homo sapiens